Novel 2.beta.-morpholino-androstane derivatives
US4894369A · kind A · utility
9Cited by
3References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 1988 |
| Grant date | Jan 16, 1990 |
| Priority date | — |
| Expiry date | Apr 13, 2008 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J71/001
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Compounds having the formula: ##STR1## wherein R.sub.1 is H or an optionally substituted acyl group having 1-12 carbon atoms, PA0 R.sub.2 is H or an acyl group having 1-12 carbon atoms and PA0 R.sub.3 is C, N--CH.sub.3 or a direct bond; and mono- or bisquaternary ammonium compounds thereof and acid addition salts of the non- or mono-quaternary ammonium compounds. Process for the preparation of these compounds. Compositions comprising at least one of the above compounds as the active ingredient. The compounds are favorable neuromuscular blocking agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.